May 7, 2021

Exeliom Biosciences opens pilot manufacturing unit for Live Biotherapeutics (LBPs) thanks to European H2020 Accelerator Program

We have reached a very exciting milestone!

We have just opened our own pilot manufacturing unit to boost our R&D efforts!

€2.5 million was the amount granted by the European Innovation Council and SMEs Executive Agency (EISMEA)'s H2020 Accelerator Program notably to support the set up of this state-of-the-art pilot unit. We also gladly benefited from the logistical support of our historical partner INRAE.

It is a major step in establishing Exeliom Biosciences as a leading player in the field of microbiome-based therapeutics.

Back to news


Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.